SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
K+S AG (KPLUY) , forward earnings yield 6.87%.
Criteria proven by this page:
- VALUE (90/100, Pass) — analyst target implies upside (+41%).
- Forward P/E 14.6
- Analyst consensus target $12.50 (+41% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 44/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
90/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — KPLUY
Valuation Multiples
P/E (TTM)0.0
Forward P/E14.6
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.91
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-2.88
Forward EPS (Est.)$0.61
Book Value / Share$0.00
Revenue / Share$9.78
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Forward Earnings Yield6.87%
Dividend Yield0.00%
Analyst Target$12.50 (+41%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.46 |
$3.46B |
$174.1M |
5% |
| 2017 |
$0.48 |
$3.63B |
$184.6M |
5.1% |
| 2018 |
$0.11 |
$4.04B |
$42.1M |
1% |
| 2019 |
$0.23 |
$4.07B |
$88.9M |
2.2% |
| 2020 |
$-4.94 |
$2.43B |
$-1.89B |
-77.7% |
| 2021 |
$5.68 |
$3.21B |
$2.17B |
67.6% |
| 2022 |
$3.94 |
$5.68B |
$1.51B |
26.6% |
| 2023 |
$0.56 |
$3.87B |
$210.2M |
5.4% |
| 2024 |
$-0.10 |
$3.65B |
$-66.8M |
-1.8% |
| 2025 |
$-2.88 |
$3.5B |
$-1.03B |
-29.5% |
